Executive Board
The Executive Board has been established to assist the Chief Executive in leading The Institute of Cancer Research to achieve its strategic aims and objectives within the approved strategies and budgets and is responsible for formulating strategies, plans and budgets for approval by the Board of Trustees.
Professor Kristian Helin
Chief Executive and President
Professor Kevin Harrington
Head of Division – Radiotherapy and Imaging
Professor Clare Isacke
Dean of Academic and Research Affairs
Paul Norris
Chief Financial Officer
Jonathan Monk
Chief Information Officer
Professor Jonathon Pines
Head of Division – Cell and Molecular Biology
Dr Barbara Pittam
Chief Research and Academic Officer
Dr Olivia Rossanese
Head of Division – Cancer Therapeutics
Dr Kary Kelly
Chief Development and Communications Officer
Latest ICR News
Childhood leukaemia and germs: research reveals the critical importance of timing
New research has endorsed a long standing idea explaining why acute lymphoblastic leukaemia (ALL) – the most common cancer in children – appears abruptly in early life, often in otherwise healthy individuals, with no obvious environmental trigger.
-growing-in-single-files-along-collagen-fibres-(red)_renee-flaherty.jpg?sfvrsn=b3bf3bc8_3 "Invasive lobular breast cells (yellow) growing in single files along collagen fibres (red)_Renee Flaherty")
The ICR and Breast Cancer Now strengthen collaborative programme to tackle lobular breast cancer
The Institute of Cancer Research, London, and Breast Cancer Now are building on their long‑standing collaboration with a major initiative focused on improving treatment for lobular breast cancer.
Newly discovered role for cancer-linked protein exposes vulnerability in tumour cells
Scientists have uncovered a previously hidden role for a protein frequently mutated in cancer, showing that it helps maintain the stability of the genome at some of its most vulnerable sites.
New understanding of enzyme regulating gene expression could inform future cancer therapies
Scientists have uncovered how an important cellular enzyme is regulated, revealing new insights into the fundamental biological processes controlling gene expression and opening up potential avenues for future cancer drug development.